216 related articles for article (PubMed ID: 8878415)
1. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.
Turner T; Chen P; Goodly LJ; Wells A
Clin Exp Metastasis; 1996 Sep; 14(4):409-18. PubMed ID: 8878415
[TBL] [Abstract][Full Text] [Related]
2. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.
Xie H; Turner T; Wang MH; Singh RK; Siegal GP; Wells A
Clin Exp Metastasis; 1995 Nov; 13(6):407-19. PubMed ID: 7586799
[TBL] [Abstract][Full Text] [Related]
3. Molecular inhibition of phospholipase cgamma signaling abrogates DU-145 prostate tumor cell invasion.
Turner T; Epps-Fung MV; Kassis J; Wells A
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2275-82. PubMed ID: 9815625
[TBL] [Abstract][Full Text] [Related]
4. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
5. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
Wells A; Souto JC; Solava J; Kassis J; Bailey KJ; Turner T
Clin Cancer Res; 2002 Apr; 8(4):1251-7. PubMed ID: 11948140
[TBL] [Abstract][Full Text] [Related]
7. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility.
Chen P; Murphy-Ullrich JE; Wells A
J Cell Biol; 1996 Aug; 134(3):689-98. PubMed ID: 8707848
[TBL] [Abstract][Full Text] [Related]
8. Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline.
Yates C; Wells A; Turner T
Br J Cancer; 2005 Jan; 92(2):366-75. PubMed ID: 15655536
[TBL] [Abstract][Full Text] [Related]
9. Calpain-2 as a target for limiting prostate cancer invasion.
Mamoune A; Luo JH; Lauffenburger DA; Wells A
Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of stimulatory guanine nucleotide binding protein (G(S)alphaQL)-mediated signaling increases invasiveness and tumorigenicity of PC-3M prostate cancer cells.
Chien J; Wong E; Nikes E; Noble MJ; Pantazis CG; Shah GV
Oncogene; 1999 Jun; 18(22):3376-82. PubMed ID: 10362358
[TBL] [Abstract][Full Text] [Related]
11. Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo.
Rabinovitz I; Nagle RB; Cress AE
Clin Exp Metastasis; 1995 Nov; 13(6):481-91. PubMed ID: 7586806
[TBL] [Abstract][Full Text] [Related]
12. EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness.
Kassis J; Maeda A; Teramoto N; Takada K; Wu C; Klein G; Wells A
Int J Cancer; 2002 Jun; 99(5):644-51. PubMed ID: 12115496
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
14. STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines.
Zhou W; Grandis JR; Wells A
Br J Cancer; 2006 Jul; 95(2):164-71. PubMed ID: 16804520
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression.
Bae VL; Jackson-Cook CK; Brothman AR; Maygarden SJ; Ware JL
Int J Cancer; 1994 Sep; 58(5):721-9. PubMed ID: 8077059
[TBL] [Abstract][Full Text] [Related]
16. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway.
Xie H; Pallero MA; Gupta K; Chang P; Ware MF; Witke W; Kwiatkowski DJ; Lauffenburger DA; Murphy-Ullrich JE; Wells A
J Cell Sci; 1998 Mar; 111 ( Pt 5)():615-24. PubMed ID: 9454735
[TBL] [Abstract][Full Text] [Related]
17. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
18. An in vivo model of prostate carcinoma growth and invasion in bone.
Fisher JL; Schmitt JF; Howard ML; Mackie PS; Choong PF; Risbridger GP
Cell Tissue Res; 2002 Mar; 307(3):337-45. PubMed ID: 11904770
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.
Chen P; Xie H; Sekar MC; Gupta K; Wells A
J Cell Biol; 1994 Nov; 127(3):847-57. PubMed ID: 7962064
[TBL] [Abstract][Full Text] [Related]
20. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]